Results 101 to 110 of about 694,618 (154)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications

, 2020
\(\bf Background\) Peritoneal metastasis (PM) in patients with breast (BC) and endometrial cancer (EC) is rare and treatment options are limited. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) has demonstrated efficacy against PM from various ...
Pabst, Urs (Dr. med.), Rezniczek, Günther (Dr. rer. nat.), Tempfer, Clemens (Prof. Dr. med.), Thaher, Omar (Dr. med.)   +3 more
core   +1 more source

Technische Analyse der Pressurized Intraperitoneal Aerosol Chemotherapy-Mikro-Injektionspumpe (MIP®/CapnoPen®)

, 2019
Hintergrund der Arbeit ist die Behandlung von Peritonealkarzinomatosen. Als ein neues Verfahren wurde die Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) beschrieben.
Falkenstein, Thomas Albert
core   +1 more source

Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy

, 2018
Background: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel mode of intraperitoneal (IP) drug delivery claiming high IP tissue concentrations with low systemic uptake.
Grass, F., Labgaa, I., Ismaïl Labgaa, Basile Pache, Teixeira Farinha, H., Pache, B., Demartines, N., Hugo Teixeira Farinha, Fabian Grass, Hübner, M., Martin Hübner, Nicolas Demartines, Teixeira Farinha H, Labgaa I, Pache B, Grass F, Hübner M, Demartines N   +17 more
core   +1 more source

Indocyanine green-activated fluorescence laparoscopy imaging: a novel quantitative assessment method for intraperitoneal aerosolized drug distribution

Holistic Integrative Oncology
Background Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an emerging treatment for peritoneal metastasis. Although its aerosol distribution is known to be inhomogeneous, quantitative assessment remains limited. This study introduces a novel
Qiming Fan, Renjie Li, Xiaosong Lin, Zifeng Yang, Yong Li   +4 more
doaj   +1 more source

Reasons for stopping Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): A retrospective study to improve future patient selection. [PDF]

PLoS One, 2023
Ezanno AC, Malgras B, Conan PL, Aime A, Fawaz J, Picchi H, Doat S, Pocard M.   +7 more
europepmc   +1 more source

PITAC: Pressurized Intrathoracic Aerosol Chemotherapy

Pressurized intrathoracic aerosol chemotherapy (PITAC) is a novel and promising treatment for malignant pleural effusion, allowing surgeons to achieve an effective pleurodesis together with a potential anti-neoplastic effect.
Maria Giovanna Mastromarino (10189318), Stylianos Korasidis (15439068), Vittorio Aprile (5095838), Marcello Carlo Ambrogi (15439069), Fabrizia Calabrò (15907942), Diana Bacchin (13559281), Marco Lucchi (583278), Gianmarco Elia (17951353)   +7 more
core   +1 more source

First reported clinical implementation of pressurized intraperitoneal aerosol chemotherapy in Japan: Program development and 30-day outcomes in two patients. [PDF]

Glob Health Med
Takeuchi H, Gohda Y, Kitayama J, Kato T, Hieda Y, Shimano H, Kudo H, Kokudo N.   +7 more
europepmc   +1 more source

Pressurized Intraperitoneal Aerosol Chemotherapy for Platinum-Resistant Ovarian Cancer: A Systematic Review and Meta-Analysis of Clinical Outcomes. [PDF]

J Clin Med
Brebu D, Faur FI, Selaru M, Cireap N, Burta C, Braicu V, Duta C, Faur IA, Pasca P, Dobrescu A, Moise GV, Ilina R.   +11 more
europepmc   +1 more source

Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery. [PDF]

Sci Rep, 2023
van de Vlasakker VCJ, Lurvink RJ, Wassenaar EC, Rauwerdink P, Bakkers C, Rovers KP, Bonhof CS, Burger JWA, Wiezer MJ, Boerma D, Nienhuijs SW, Mols F, de Hingh IHJT.   +12 more
europepmc   +1 more source

Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in suboptimally cytoreduced advanced ovarian cancer: a randomized phase II trial (PIPAC-OVA). [PDF]

BMC Cancer
Dzasokhov AS, Khomyakov VM, Turiev AV, Astashov VL, Kostin AA, Gunyakov SO, Andreeva MA.   +6 more
europepmc   +1 more source